Mr. David Lawrence, M.B.A., is Chief Financial Officer of Acorda Therapeutics, Inc., since January 2005. He previously served as Vice President, Finance from January 2001 through 2004, and Director, Finance from 1999 to 2001. From 1991 to 1999, Mr. Lawrence held several positions for TelAir Communications, Inc. including Vice President and Controller. Prior to TelAir, he held the financial management positions of Controller and Finance Manager for Southwestern Bell and Metromedia Telecommunications, respectively. Mr. Lawrence received his undergraduate degree in Accounting from Roger Williams College, and an M.B.A in Finance from Iona College. Mr. Lawrence is a founding member and currently serves on the board of directors and as Treasurer of The Brian Ahearn Children?s Fund.
The company has return on total asset (ROA) of 1.96 % which means that it generated profit of $1.96 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 47.8 % meaning that it created $47.8 on every $100 dollars invested by stockholders.
The company currently holds 4.28 M in liabilities with Debt to Equity (D/E) ratio of 0.01 which may suggest the company is not taking enough advantage from borrowing. Acorda Therapeutics Inc has Current Ratio of 3.96 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Acorda Therapeutics, Inc., a commercialstage biopharmaceutical company, engages in the identification, development, and commercialization of therapies for multiple sclerosis , spinal cord injury , and other central nervous system disorders primarily in the United States. Acorda Therapeutics Inc [ACOR] is traded on NASDAQ in USA. It is located in Acorda Therapeutics, Inc.Ardsley, NY and employs 378 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
Nasdaq Acorda Therapeutics Inc
0.78% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Frankfurt
